Vectors Research Management LLC lifted its position in Livent Co. (NYSE:LTHM – Get Rating) by 4.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 10,984 shares of the company's stock after acquiring an additional 447 shares during the period. Vectors Research Management LLC's holdings in Livent were worth $337,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in LTHM. BlackRock Inc. increased its stake in shares of Livent by 3.2% in the first quarter. BlackRock Inc. now owns 25,674,467 shares of the company's stock worth $669,334,000 after acquiring an additional 797,187 shares during the period. Vanguard Group Inc. grew its position in Livent by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 17,627,545 shares of the company's stock worth $459,549,000 after purchasing an additional 109,353 shares during the period. Wellington Management Group LLP raised its stake in shares of Livent by 5.7% during the 1st quarter. Wellington Management Group LLP now owns 7,824,996 shares of the company's stock valued at $203,997,000 after buying an additional 421,082 shares during the last quarter. State Street Corp lifted its holdings in shares of Livent by 1.9% in the 2nd quarter. State Street Corp now owns 5,289,249 shares of the company's stock valued at $120,013,000 after buying an additional 99,374 shares during the period. Finally, Invesco Ltd. grew its holdings in Livent by 2.2% during the first quarter. Invesco Ltd. now owns 2,136,522 shares of the company's stock worth $55,700,000 after acquiring an additional 46,870 shares during the period. Hedge funds and other institutional investors own 90.62% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Bank of America upgraded Livent from an "underperform" rating to a "buy" rating and lowered their price objective for the stock from $27.00 to $26.00 in a research report on Wednesday, January 11th. Piper Sandler dropped their price target on shares of Livent from $42.00 to $38.00 and set an "overweight" rating on the stock in a research report on Thursday, December 15th. Mizuho decreased their price objective on shares of Livent from $31.00 to $27.00 and set a "neutral" rating for the company in a research report on Thursday, January 12th. Deutsche Bank Aktiengesellschaft dropped their target price on Livent from $30.00 to $22.00 in a research report on Tuesday, January 10th. Finally, Vertical Research upgraded Livent from a "hold" rating to a "buy" rating and set a $30.00 price target for the company in a research note on Wednesday, January 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Livent currently has an average rating of "Moderate Buy" and an average price target of $28.78.

Livent Price Performance

Livent (NYSE:LTHM – Get Rating) last issued its quarterly earnings results on Tuesday, November 1st. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. The firm had revenue of $231.60 million during the quarter, compared to analysts' expectations of $248.19 million. Livent had a return on equity of 20.00% and a net margin of 27.67%. As a group, analysts predict that Livent Co. will post 1.35 EPS for the current fiscal year.

Livent Profile

(Get Rating)

Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, Latin America, and Asia Pacific.

Further Reading

• Get a free copy of the StockNews.com research report on Livent (LTHM)
• MarketBeat Week in Review – 1/30 – 2/3
• Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
• Zimmer Biomet Beats on Earnings, Growth May be Priced In
• AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
• Ford Stock Going Forward After Big Earnings Flop

Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Co. (NYSE:LTHM – Get Rating).

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.